Skip to content
Saturday, October 17, 2026 Market moodBearish−16.9
Sign in
GlideslopeGlideslopeGlideslope AI-powered market news
GlideslopeGlideslopeGlideslope
Market mood−16.9
Breaking
CNBC TOP STORIES These tech stocks are a buy ahead of their earnings reports, Bank of America says Neutral BUSINESS INSIDER The 20 global cities with the best quality of life Strong Bullish THE GUARDIAN US NEWS After the unimaginable happens, an Oregon town mourns: ‘You can’t stop thinking about the… Bearish MARKET WATCH Silver’s recent 50% drop from a record high hints that an economic slowdown looms Strong Bullish BUSINESS INSIDER How a cruise ship navigates Greenland's icebergs and extreme Arctic conditions Bearish CBS NEWS Hero bystander, teacher praised for saving lives in school shooting Optimistic BUSINESS INSIDER My partner and I don't share a bank account, and we still won't after our wedding Neutral CBS NEWS Killers of U.S., Australian surf trio sentenced to 158 years Pessimistic MARKET WATCH Microsoft, Shopify and 3 more AI stocks that are favorite Wall Street earnings plays Bullish THE GUARDIAN US NEWS CDC to send ‘disease detective’ to help tackle Pennsylvania measles outbreak Neutral CBS NEWS Woman, 26, felt her concerns were being dismissed before cancer diagnosis Pessimistic NEW YORK TIMES BUSINESS States Are Stepping Up as the New Antitrust Enforcers Neutral FOX NEWS US Detective suspected in girl’s murder may have killed others, former investigator fears Pessimistic CNBC FINANCE Bending Spoons wants to revive software castoffs. Berkshire is backing the plan Strong Bullish WIRED Encryption Is Getting Squeezed From All Sides Neutral THE VERGE Apple’s HomeView is just the latest threat to online recipe writers Neutral THE VERGE It’s a dream week for tech docs Neutral BUSINESS INSIDER I downsized from a 3-bedroom to a 2-bedroom when I got married. There's one thing I miss. Pessimistic BUSINESS INSIDER I was diagnosed with breast cancer a year ago. Please stop calling me a fighter. Neutral CBS NEWS Vance says it's going to take time to turn around the economy Pessimistic CNBC TOP STORIES These tech stocks are a buy ahead of their earnings reports, Bank of America says Neutral BUSINESS INSIDER The 20 global cities with the best quality of life Strong Bullish THE GUARDIAN US NEWS After the unimaginable happens, an Oregon town mourns: ‘You can’t stop thinking about the… Bearish MARKET WATCH Silver’s recent 50% drop from a record high hints that an economic slowdown looms Strong Bullish BUSINESS INSIDER How a cruise ship navigates Greenland's icebergs and extreme Arctic conditions Bearish CBS NEWS Hero bystander, teacher praised for saving lives in school shooting Optimistic BUSINESS INSIDER My partner and I don't share a bank account, and we still won't after our wedding Neutral CBS NEWS Killers of U.S., Australian surf trio sentenced to 158 years Pessimistic MARKET WATCH Microsoft, Shopify and 3 more AI stocks that are favorite Wall Street earnings plays Bullish THE GUARDIAN US NEWS CDC to send ‘disease detective’ to help tackle Pennsylvania measles outbreak Neutral CBS NEWS Woman, 26, felt her concerns were being dismissed before cancer diagnosis Pessimistic NEW YORK TIMES BUSINESS States Are Stepping Up as the New Antitrust Enforcers Neutral FOX NEWS US Detective suspected in girl’s murder may have killed others, former investigator fears Pessimistic CNBC FINANCE Bending Spoons wants to revive software castoffs. Berkshire is backing the plan Strong Bullish WIRED Encryption Is Getting Squeezed From All Sides Neutral THE VERGE Apple’s HomeView is just the latest threat to online recipe writers Neutral THE VERGE It’s a dream week for tech docs Neutral BUSINESS INSIDER I downsized from a 3-bedroom to a 2-bedroom when I got married. There's one thing I miss. Pessimistic BUSINESS INSIDER I was diagnosed with breast cancer a year ago. Please stop calling me a fighter. Neutral CBS NEWS Vance says it's going to take time to turn around the economy Pessimistic
CNBC Top Stories · Jun 22, 2026 11:49 AM EDT Healthcare

AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push

AbbVie said on Monday it would buy biotech Apogee ⁠Therapeutics for $10.9 billion, in more than ​five years.

AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push
Image CNBC Top Stories

AI brief

Pulse reads the full article
What happened
Why it matters
What to watch

Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.

Sign in to read the brief
● MACRO ANALYST

Apex+

Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.

LOG IN / SUBSCRIBE